Sathyan, A. et al. 2025. A Comprehensive Review of Evidence and Challenges in Switching from Originator Drugs to Biosimilars of Monoclonal Antibodies: Focus on Rituximab and Trastuzumab. Journal of Drug Delivery and Therapeutics. 15, 2 (Feb. 2025), 149–155. DOI:https://doi.org/10.22270/jddt.v15i2.7012.